Nokia strikes $191M deal for French digital health startup

Nokia CEO Rajeev Suri

It seems like everyone is jumping into the health monitoring market these days, and Nokia is no exception. The company is snatching up French company Withings for €170 million ($191 million) to gain ground in digital health.

Through the agreement, Nokia will get its hands on Withings' med tech portfolio, including activity trackers, weighing scales, thermometers, blood pressure monitors and home monitors. Small cap Withings, which has about 200 employees, will be integrated into Nokia's Technologies unit. The business comprises Nokia's patent portfolio and some consumer products.

The companies expect to close the all-cash deal in early Q3 2016, Finland-based Nokia said in a statement.

"We have said consistently that digital health was an area of strategic interest to Nokia, and we are now taking concrete action to tap the opportunity in this large and important market," Nokia CEO Rajeev Suri said in a statement. The deal "leverages the power of our trusted brand, fits with our company purpose of expanding the human possibilities of the connected world, and puts us at the heart of a very large addressable market where we can make a meaningful difference in people's lives," Suri said.

A deal for Withings will help Nokia compete with some bigger names on the patient monitoring block. Qualcomm ($QCOM), a leader in the field, is already making strides with its digital health tech. The company recently struck a deal with UnitedHealthcare ($UNH) to develop connected health services for the insurer's employer wellness program.

Nokia hit $5.95 in premarket trading upon news of the deal.

- read the statement

Suggested Articles

Smith+Nephew is contracting with the U.K. government to build a new ventilator specifically designed for large-scale production.

NantWorks’ ImmunityBio has begun a supercomputing collaboration with Microsoft to map out the spike protein of the novel coronavirus.

President Emmanuel Ligner talks about finalizing a multibillion-dollar deal while adjusting and responding to the global COVID-19 crisis.